Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$4.97 Billion

According to Galapagos NV's latest financial reports the company has NZ$4.97 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Galapagos NV - Net assets on balance sheet (from 2008 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$5.34 B9.38%
2023-12-31$NZ$4.88 B14.5%
2022-12-31$NZ$4.26 B-2.62%
2021-12-31$NZ$4.38 B-3.72%
2020-12-31$NZ$4.55 B-4.83%
2019-12-31$NZ$4.78 B130.97%
2018-12-31$NZ$2.07 B21.13%
2017-12-31$NZ$1.70 B48.4%
2016-12-31$NZ$1.15 B97.58%
2015-12-31$NZ$0.58 B82.24%
2014-12-31$NZ$0.31 B13.92%
2013-12-31$NZ$0.28 B47.48%
2012-12-31$NZ$0.19 B-3.31%
2011-12-31$NZ$0.19 B-23.07%
2010-12-31$NZ$0.25 B19.22%
2009-12-31$NZ$0.21 B5.72%
2008-12-31$NZ$0.20 B8.05%
2007-12-31$NZ$0.18 B-8.37%
2006-12-31$NZ$0.20 B93.63%
2005-12-31$NZ$0.10 B437.63%
2004-12-31$NZ$19.7 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
AstraZeneca
AZN
NZ$79.57 B 1,500.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$137.22 B 2,660.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.38 B 2,905.07%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
-NZ$4.5 Billion-190.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$64.7 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$88.73 B 1,685.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$12.55 B 152.60%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$36.65 B 637.40%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$89.85 B 1,707.52%๐Ÿ‡บ๐Ÿ‡ธ USA